Jarosław Paluszczak

ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 19

Top Venues

Current issues in molecular biology

Cells

Biomedicines

Antioxidants (Basel, Switzerland)

Poznan University of Medical Sciences

Poznan University of Medical Sciences (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Poznan University of Medical Sciences

Poland

Associate Professor :: Department of Pharmaceutical Biochemistry

Education History

Poznan University of Medical Sciences

Poland

PHD

Publications

Dawid Dorna, Robert Kleszcz, Jarosław Paluszczak
Triple Combinations of Histone Lysine Demethylase Inhibitors with PARP1 Inhibitor-Olaparib and Cisplatin Lead to Enhanced Cytotoxic Effects in Head and Neck Cancer Cells. Biomedicines 12 (6) (2024)
Dawid Dorna, Robert Kleszcz, Jarosław Paluszczak
Triple Combinations of Histone Lysine Demethylase Inhibitors with PARP1 Inhibitor-Olaparib and Cisplatin Lead to Enhanced Cytotoxic Effects in Head and Neck Cancer Cells. Biomedicines 12 (6) (2024)
Elżbieta Studzińska-Sroka, Magdalena Paczkowska-Walendowska, Cansu Erdem, Jarosław Paluszczak, Robert Kleszcz, Marta Hoszman-Kulisz, Judyta Cielecka-Piontek
Anti-Aging Properties of Chitosan-Based Hydrogels Rich in Bilberry Fruit Extract. Antioxidants (Basel, Switzerland) 13 (1) (2024)
Elżbieta Studzińska-Sroka, Magdalena Paczkowska-Walendowska, Cansu Erdem, Jarosław Paluszczak, Robert Kleszcz, Marta Hoszman-Kulisz, Judyta Cielecka-Piontek
Anti-Aging Properties of Chitosan-Based Hydrogels Rich in Bilberry Fruit Extract. Antioxidants (Basel, Switzerland) 13 (1) (2024)
Robert Kleszcz, Jarosław Paluszczak, Marta Belka, Violetta Krajka-Kuzniak
PRI-724 and IWP-O1 Wnt Signaling Pathway Inhibitors Modulate the Expression of Glycolytic Enzymes in Tongue Cancer Cell Lines. Current issues in molecular biology 45 (12) (2023)
Robert Kleszcz, Mikołaj Frąckowiak, Dawid Dorna, Jarosław Paluszczak
Combinations of PRI-724 Wnt/β-Catenin Pathway Inhibitor with Vismodegib, Erlotinib, or HS-173 Synergistically Inhibit Head and Neck Squamous Cancer Cells. International journal of molecular sciences 24 (13) (2023)
Robert Kleszcz, Jarosław Paluszczak, Marta Belka, Violetta Krajka-Kuzniak
PRI-724 and IWP-O1 Wnt Signaling Pathway Inhibitors Modulate the Expression of Glycolytic Enzymes in Tongue Cancer Cell Lines. Current issues in molecular biology 45 (12) (2023)
Robert Kleszcz, Jarosław Paluszczak, Marta Belka, Violetta Krajka-Kuzniak
PRI-724 and IWP-O1 Wnt Signaling Pathway Inhibitors Modulate the Expression of Glycolytic Enzymes in Tongue Cancer Cell Lines. Current issues in molecular biology 45 (12) (2023)
Dawid Dorna, Adriana Grabowska, Jarosław Paluszczak
Natural products modulating epigenetic mechanisms by affecting histone methylation/demethylation: targeting cancer cells. British journal of pharmacology (2023)
Dawid Dorna, Jarosław Paluszczak
Targeting cancer stem cells as a strategy for reducing chemotherapy resistance in head and neck cancers. Journal of cancer research and clinical oncology (2023)
Dawid Dorna, Jarosław Paluszczak
The Emerging Significance of Histone Lysine Demethylases as Prognostic Markers and Therapeutic Targets in Head and Neck Cancers. Cells 11 (6) (2022)
Robert Kleszcz, Jarosław Paluszczak
The Wnt Signaling Pathway Inhibitors Improve the Therapeutic Activity of Glycolysis Modulators against Tongue Cancer Cells. International journal of molecular sciences 23 (3) (2022)
Marta Cykowiak, Robert Kleszcz, Małgorzata Kucińska, Jarosław Paluszczak, Hanna Szaefer, Adam Plewiński, Hanna Piotrowska-Kempisty, Marek Murias, Violetta Krajka-Kuzniak
Attenuation of Pancreatic Cancer In Vitro and In Vivo via Modulation of Nrf2 and NF-κB Signaling Pathways by Natural Compounds. Cells 10 (12) (2021)
Katarzyna Papierska, Violetta Krajka-Kuzniak, Jarosław Paluszczak, Robert Kleszcz, Marcin Skalski, Elżbieta Studzińska-Sroka, Wanda Baer-Dubowska
Lichen-Derived Depsides and Depsidones Modulate the Nrf2, NF-κB and STAT3 Signaling Pathways in Colorectal Cancer Cells. Molecules (Basel, Switzerland) 26 (16) (2021)
Robert Kleszcz, Jarosław Paluszczak
The combinatorial inhibition of Wnt signaling and Akt kinase is beneficial for reducing the survival and glycolytic activity of tongue cancer cells. Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology (2021)
Jarosław Paluszczak
The Significance of the Dysregulation of Canonical Wnt Signaling in Head and Neck Squamous Cell Carcinomas. Cells 9 (3) (2020)
Robert Kleszcz, Anna Szymańska, Violetta Krajka-Kuźniak, Wanda Baer-Dubowska, Jarosław Paluszczak
Inhibition of CBP/β-catenin and porcupine attenuates Wnt signaling and induces apoptosis in head and neck carcinoma cells. Cellular oncology (Dordrecht) 42 (4) (2019)
Jarosław Paluszczak, Robert Kleszcz, Elżbieta Studzińska-Sroka, Violetta Krajka-Kuźniak
Lichen-derived caperatic acid and physodic acid inhibit Wnt signaling in colorectal cancer cells. Molecular and cellular biochemistry 441 (1-2) (2017)
Jarosław Paluszczak, Dorota Wiśniewska, Magdalena Kostrzewska-Poczekaj, Katarzyna Kiwerska, Reidar Grénman, Daniela Mielcarek-Kuchta, Małgorzata Jarmuż-Szymczak
Prognostic significance of the methylation of Wnt pathway antagonists-CXXC4, DACT2, and the inhibitors of sonic hedgehog signaling-ZIC1, ZIC4, and HHIP in head and neck squamous cell carcinomas. Clinical oral investigations 21 (5) (2016)

Jarosław Paluszczak.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jarosław Paluszczak